[1]
Kim WB. On trichotillomania and its hairy history. JAMA dermatology. 2014 Nov:150(11):1179. doi: 10.1001/jamadermatol.2014.2284. Epub
[PubMed PMID: 25389789]
[2]
Monzani B, Rijsdijk F, Harris J, Mataix-Cols D. The structure of genetic and environmental risk factors for dimensional representations of DSM-5 obsessive-compulsive spectrum disorders. JAMA psychiatry. 2014 Feb:71(2):182-9. doi: 10.1001/jamapsychiatry.2013.3524. Epub
[PubMed PMID: 24369376]
[3]
Slikboer R, Reser MP, Nedeljkovic M, Castle DJ, Rossell SL. Systematic Review of Published Primary Studies of Neuropsychology and Neuroimaging in Trichotillomania. Journal of the International Neuropsychological Society : JINS. 2018 Feb:24(2):188-205. doi: 10.1017/S1355617717000819. Epub 2017 Aug 24
[PubMed PMID: 28835311]
Level 1 (high-level) evidence
[4]
Chamberlain SR, Harries M, Redden SA, Keuthen NJ, Stein DJ, Lochner C, Grant JE. Cortical thickness abnormalities in trichotillomania: international multi-site analysis. Brain imaging and behavior. 2018 Jun:12(3):823-828. doi: 10.1007/s11682-017-9746-3. Epub
[PubMed PMID: 28664230]
[5]
Chamberlain SR, Menzies LA, Fineberg NA, Del Campo N, Suckling J, Craig K, Müller U, Robbins TW, Bullmore ET, Sahakian BJ. Grey matter abnormalities in trichotillomania: morphometric magnetic resonance imaging study. The British journal of psychiatry : the journal of mental science. 2008 Sep:193(3):216-21. doi: 10.1192/bjp.bp.107.048314. Epub
[PubMed PMID: 18757980]
[6]
Roos A, Fouche JP, Stein DJ, Lochner C. White matter integrity in hair-pulling disorder (trichotillomania). Psychiatry research. 2013 Mar 30:211(3):246-50. doi: 10.1016/j.pscychresns.2012.08.005. Epub 2012 Nov 11
[PubMed PMID: 23149033]
[7]
Woods DW, Houghton DC. Diagnosis, evaluation, and management of trichotillomania. The Psychiatric clinics of North America. 2014 Sep:37(3):301-17. doi: 10.1016/j.psc.2014.05.005. Epub 2014 Jul 21
[PubMed PMID: 25150564]
[8]
Krooks JA, Weatherall AG, Holland PJ. Review of epidemiology, clinical presentation, diagnosis, and treatment of common primary psychiatric causes of cutaneous disease. The Journal of dermatological treatment. 2018 Jun:29(4):418-427. doi: 10.1080/09546634.2017.1395389. Epub 2017 Nov 5
[PubMed PMID: 29052453]
[9]
Rothbart R, Stein DJ. Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review. Expert opinion on pharmacotherapy. 2014 Dec:15(18):2709-19. doi: 10.1517/14656566.2014.972936. Epub
[PubMed PMID: 25399534]
Level 3 (low-level) evidence
[10]
Rothbart R, Amos T, Siegfried N, Ipser JC, Fineberg N, Chamberlain SR, Stein DJ. Pharmacotherapy for trichotillomania. The Cochrane database of systematic reviews. 2013 Nov 8:(11):CD007662. doi: 10.1002/14651858.CD007662.pub2. Epub 2013 Nov 8
[PubMed PMID: 24214100]
Level 1 (high-level) evidence
[11]
McGuire JF, Ung D, Selles RR, Rahman O, Lewin AB, Murphy TK, Storch EA. Treating trichotillomania: a meta-analysis of treatment effects and moderators for behavior therapy and serotonin reuptake inhibitors. Journal of psychiatric research. 2014 Nov:58():76-83. doi: 10.1016/j.jpsychires.2014.07.015. Epub 2014 Jul 26
[PubMed PMID: 25108618]
Level 1 (high-level) evidence
[12]
Yasui-Furukori N, Kaneko S. The efficacy of low-dose aripiprazole treatment for trichotillomania. Clinical neuropharmacology. 2011 Nov-Dec:34(6):258-9. doi: 10.1097/WNF.0b013e318237b2c7. Epub
[PubMed PMID: 22104636]
[13]
Van Ameringen M, Mancini C, Patterson B, Bennett M, Oakman J. A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania. The Journal of clinical psychiatry. 2010 Oct:71(10):1336-43. doi: 10.4088/JCP.09m05114gre. Epub 2010 Apr 20
[PubMed PMID: 20441724]
Level 1 (high-level) evidence
[14]
Jefferys D, Burrows G. Reversal of trichotillomania with aripiprazole. Depression and anxiety. 2008:25(6):E37-40
[PubMed PMID: 17941109]
[15]
Swedo SE, Leonard HL, Rapoport JL, Lenane MC, Goldberger EL, Cheslow DL. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). The New England journal of medicine. 1989 Aug 24:321(8):497-501
[PubMed PMID: 2761586]
Level 1 (high-level) evidence
[16]
Stanley MA, Hannay HJ, Breckenridge JK. The neuropsychology of trichotillomania. Journal of anxiety disorders. 1997 Sep-Oct:11(5):473-88
[PubMed PMID: 9407267]
[17]
White MP, Shirer WR, Molfino MJ, Tenison C, Damoiseaux JS, Greicius MD. Disordered reward processing and functional connectivity in trichotillomania: a pilot study. Journal of psychiatric research. 2013 Sep:47(9):1264-72. doi: 10.1016/j.jpsychires.2013.05.014. Epub 2013 Jun 15
[PubMed PMID: 23777938]
Level 3 (low-level) evidence
[18]
Shareh H. A Preliminary Investigation of Metacognitive Therapy and Habit Reversal as a Treatment for Trichotillomania. Behavioural and cognitive psychotherapy. 2018 Jan:46(1):1-20. doi: 10.1017/S1352465817000546. Epub 2017 Sep 14
[PubMed PMID: 28903787]
[19]
Grzesiak M, Reich A, Szepietowski JC, Hadryś T, Pacan P. Trichotillomania Among Young Adults: Prevalence and Comorbidity. Acta dermato-venereologica. 2017 Apr 6:97(4):509-512. doi: 10.2340/00015555-2565. Epub
[PubMed PMID: 27827514]
[20]
Lochner C, Grant JE, Odlaug BL, Woods DW, Keuthen NJ, Stein DJ. DSM-5 field survey: hair-pulling disorder (trichotillomania). Depression and anxiety. 2012 Dec:29(12):1025-31. doi: 10.1002/da.22011. Epub 2012 Nov 1
[PubMed PMID: 23124891]
Level 3 (low-level) evidence
[21]
Gupta MA, Gupta AK, Knapp K. Trichotillomania: Demographic and Clinical Features From a Nationally Representative US Sample. Skinmed. 2015:13(6):455-60
[PubMed PMID: 26861522]
[22]
Hamid M, Chaoui Y, Mountasser M, Sabbah F, Raiss M, Hrora A, Alaoui M, Ahallat M, Chaouch S, Ouazzani H. Giant gastric trichobezoar in a young female with Rapunzel syndrome: case report. The Pan African medical journal. 2017:27():252. doi: 10.11604/pamj.2017.27.252.9110. Epub 2017 Aug 4
[PubMed PMID: 29187921]
Level 3 (low-level) evidence
[23]
Stefanato CM. Histopathology of alopecia: a clinicopathological approach to diagnosis. Histopathology. 2010 Jan:56(1):24-38. doi: 10.1111/j.1365-2559.2009.03439.x. Epub
[PubMed PMID: 20055903]
[24]
Lewin AB, Wu MS, McGuire JF, Storch EA. Cognitive behavior therapy for obsessive-compulsive and related disorders. The Psychiatric clinics of North America. 2014 Sep:37(3):415-45. doi: 10.1016/j.psc.2014.05.002. Epub 2014 Jul 18
[PubMed PMID: 25150570]
[25]
Crescente Junior JA, Guzman CS, Tavares H. Quetiapine for the treatment of trichotillomania. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999). 2008 Dec:30(4):402
[PubMed PMID: 19142421]
[26]
Barroso LAL, Sternberg F, Souza MNIFE, Nunes GJB. Trichotillomania: a good response to treatment with N-acetylcysteine. Anais brasileiros de dermatologia. 2017 Jul-Aug:92(4):537-539. doi: 10.1590/abd1806-4841.20175435. Epub
[PubMed PMID: 28954106]
[27]
Carr JM, Mortimer H, Martin K, Kaur M, Goulding JMR. A retrospective review of 12 patients with trichotillomania treated in a psychodermatology service. Clinical and experimental dermatology. 2019 Aug:44(6):658-660. doi: 10.1111/ced.13931. Epub 2019 Feb 25
[PubMed PMID: 30689239]
Level 2 (mid-level) evidence